Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-30 @ 6:44 AM
Study NCT ID:
NCT01023568
Status:
TERMINATED
Last Update Posted:
2017-02-02
First Post:
2009-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'johnsor13@ccf.org', 'phone': '216-444-9950', 'title': 'Roberta Johnson', 'organization': 'Cleveland Clinic'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'eventGroups': [{'id': 'EG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope', 'otherNumAtRisk': 45, 'otherNumAffected': 0, 'seriousNumAtRisk': 45, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.', 'otherNumAtRisk': 44, 'otherNumAffected': 0, 'seriousNumAtRisk': 44, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.', 'otherNumAtRisk': 45, 'otherNumAffected': 0, 'seriousNumAtRisk': 45, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Time to Successfully Intubate Patient.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'OG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'OG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'classes': [{'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000', 'lowerLimit': '21', 'upperLimit': '28'}, {'value': '39', 'groupId': 'OG001', 'lowerLimit': '31', 'upperLimit': '59'}, {'value': '44', 'groupId': 'OG002', 'lowerLimit': '28', 'upperLimit': '62'}]}]}], 'analyses': [{'pValue': '>0.99', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Median Difference (Final Values)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '14', 'ciLowerLimit': '7', 'ciUpperLimit': '26', 'estimateComment': 'Glidescope - direct laryngoscopy', 'statisticalMethod': 'Wilcoxon (Mann-Whitney)', 'nonInferiorityType': 'NON_INFERIORITY_OR_EQUIVALENCE', 'testedNonInferiority': True, 'nonInferiorityComment': 'The GlideScope and Truview PCD video laryngoscopes were individually assessed for non-inferiority on time to intubation vs direct laryngoscopy at the 0.025 significance level using an a priori specified non-inferiority delta of seven seconds (about 40% of the expected standard deviation of 18 sec and not thought to be clinically important).'}, {'pValue': '>0.99', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Median Difference (Final Values)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '17', 'ciLowerLimit': '6', 'ciUpperLimit': '28', 'estimateComment': 'Truview PCD - direct laryngoscopy', 'statisticalMethod': 'Wilcoxon (Mann-Whitney)', 'nonInferiorityType': 'NON_INFERIORITY_OR_EQUIVALENCE', 'testedNonInferiority': True, 'nonInferiorityComment': 'The GlideScope and Truview PCD video laryngoscopes were individually assessed for non-inferiority on time to intubation vs direct laryngoscopy at the 0.025 significance level using an a priori specified non-inferiority delta of seven seconds (about 40% of the expected standard deviation of 18 sec and not thought to be clinically important).'}], 'paramType': 'MEDIAN', 'timeFrame': 'from start of intubation to successfully intubated up to 5 minutes', 'unitOfMeasure': 'seconds', 'dispersionType': 'Inter-Quartile Range', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Mean Hemodynamic Response: Mean Arterial Blood Pressure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'OG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'OG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'classes': [{'categories': [{'measurements': [{'value': '62', 'spread': '12', 'groupId': 'OG000'}, {'value': '63', 'spread': '9', 'groupId': 'OG001'}, {'value': '66', 'spread': '12', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.28', 'groupIds': ['OG000', 'OG001', 'OG002'], 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes', 'unitOfMeasure': 'mmHg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Cormack-Lehane Grade', 'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'OG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'OG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'classes': [{'title': '1: Full view of glottis', 'categories': [{'measurements': [{'value': '34', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '37', 'groupId': 'OG002'}]}]}, {'title': '2: Partial view of glottis', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': '3: Only epiglottis seen, none of glottis seen', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '23', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}, {'title': '4: Neither glottis nor epiglottis seen', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '> 0.99', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Median Difference (Final Values)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '1', 'ciLowerLimit': '1', 'ciUpperLimit': '2', 'estimateComment': 'The median difference was Hodges-Lehmann estimation and the confidence intervals were exact confidence limits. The SAS "NPAR1WAY" procedure was used for test and estimation.', 'groupDescription': 'The Cormack-Lehane grade with a grade 1 (best grade) to 4 (worst grade) was analyzed as an ordinal outcome.', 'statisticalMethod': 'Wilcoxon (Mann-Whitney)', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': '1-tailed Wilcoxon sum-rank test', 'testedNonInferiority': False}, {'pValue': '0.18', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Median Difference (Final Values)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0', 'ciLowerLimit': '0', 'ciUpperLimit': '0', 'estimateComment': 'The median difference was Hodges-Lehmann estimation and the confidence intervals were exact confidence limits. The SAS "NPAR1WAY" procedure was used for test and estimation.', 'groupDescription': 'The Cormack-Lehane grade with a grade 1 (best grade) to 4 (worst grade) was analyzed as an ordinal outcome.', 'statisticalMethod': 'Wilcoxon (Mann-Whitney)', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': '1-tailed Wilcoxon sum-rank test', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'immediately after intubation', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Mean Hemodynamic Response: Heart Rate', 'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'OG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'OG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'classes': [{'categories': [{'measurements': [{'value': '126', 'spread': '21', 'groupId': 'OG000'}, {'value': '127', 'spread': '15', 'groupId': 'OG001'}, {'value': '128', 'spread': '18', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.26', 'groupIds': ['OG000', 'OG001', 'OG002'], 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes.', 'unitOfMeasure': 'beats/min', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Number of Participants Who Experienced Desaturation', 'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'OG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'OG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'classes': [{'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '>0.99', 'groupIds': ['OG000', 'OG001', 'OG002'], 'statisticalMethod': 'Chi-squared', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes.', 'description': 'Desaturation was defined as SpO2 less than 90% at induction time or any time from intubation to 10 minutes after', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'FG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'FG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '45'}, {'groupId': 'FG001', 'numSubjects': '44'}, {'groupId': 'FG002', 'numSubjects': '45'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '45'}, {'groupId': 'FG001', 'numSubjects': '44'}, {'groupId': 'FG002', 'numSubjects': '45'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '45', 'groupId': 'BG000'}, {'value': '44', 'groupId': 'BG001'}, {'value': '45', 'groupId': 'BG002'}, {'value': '134', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Macintosh Blade', 'description': 'Intubation with Macintosh blade laryngoscope\n\nMacintosh blade: Intubation with Macintosh blade laryngoscope'}, {'id': 'BG001', 'title': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope\n\nGlidescope: Intubation with Glidescope laryngoscope.'}, {'id': 'BG002', 'title': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope\n\nTruview PCD: Intubation with Truview PCD laryngoscope.'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '4.0', 'spread': '2.8', 'groupId': 'BG000'}, {'value': '4.6', 'spread': '2.7', 'groupId': 'BG001'}, {'value': '5.2', 'spread': '2.8', 'groupId': 'BG002'}, {'value': '4.6', 'spread': '2.8', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Gender', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '16', 'groupId': 'BG000'}, {'value': '11', 'groupId': 'BG001'}, {'value': '14', 'groupId': 'BG002'}, {'value': '41', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '29', 'groupId': 'BG000'}, {'value': '33', 'groupId': 'BG001'}, {'value': '31', 'groupId': 'BG002'}, {'value': '93', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Body mass index', 'classes': [{'categories': [{'measurements': [{'value': '17', 'groupId': 'BG000', 'lowerLimit': '15', 'upperLimit': '19'}, {'value': '16', 'groupId': 'BG001', 'lowerLimit': '15', 'upperLimit': '18'}, {'value': '16', 'groupId': 'BG002', 'lowerLimit': '16', 'upperLimit': '18'}, {'value': '16.5', 'groupId': 'BG003', 'lowerLimit': '15.4', 'upperLimit': '18.8'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'kg/m2', 'dispersionType': 'INTER_QUARTILE_RANGE'}, {'title': 'ASA physical status', 'classes': [{'title': 'I: A normal healthy patient', 'categories': [{'measurements': [{'value': '19', 'groupId': 'BG000'}, {'value': '20', 'groupId': 'BG001'}, {'value': '19', 'groupId': 'BG002'}, {'value': '58', 'groupId': 'BG003'}]}]}, {'title': 'II: A patient with mild systemic disease', 'categories': [{'measurements': [{'value': '24', 'groupId': 'BG000'}, {'value': '23', 'groupId': 'BG001'}, {'value': '25', 'groupId': 'BG002'}, {'value': '72', 'groupId': 'BG003'}]}]}, {'title': 'III: A patient with severe systemic disease', 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}, 'primaryPurpose': 'SUPPORTIVE_CARE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 134}}, 'statusModule': {'whyStopped': 'The study was stopped for futility at the first interim analysis', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2009-12'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-12', 'completionDateStruct': {'date': '2011-05', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2016-12-08', 'studyFirstSubmitDate': '2009-12-01', 'resultsFirstSubmitDate': '2016-06-21', 'studyFirstSubmitQcDate': '2009-12-01', 'lastUpdatePostDateStruct': {'date': '2017-02-02', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2016-12-08', 'studyFirstPostDateStruct': {'date': '2009-12-02', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2017-02-02', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2011-05', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Time to Successfully Intubate Patient.', 'timeFrame': 'from start of intubation to successfully intubated up to 5 minutes'}], 'secondaryOutcomes': [{'measure': 'Mean Hemodynamic Response: Mean Arterial Blood Pressure', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes'}, {'measure': 'Cormack-Lehane Grade', 'timeFrame': 'immediately after intubation'}, {'measure': 'Mean Hemodynamic Response: Heart Rate', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes.'}, {'measure': 'Number of Participants Who Experienced Desaturation', 'timeFrame': 'measured at 1 minute interval at induction time and from intubation for 10 minutes.', 'description': 'Desaturation was defined as SpO2 less than 90% at induction time or any time from intubation to 10 minutes after'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['intubation', 'pediatric', 'videolaryngoscope devices'], 'conditions': ['Intubation']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to compare the effectiveness of two novel videolaryngoscope systems, the Glidescope and the Truview PCD against standard direct laryngoscopy (DL) in pediatric patients. The investigators primary hypothesis is that the use of videolaryngoscope devices, Glidescope and Truview provide better laryngeal views in pediatric patients as measured by Cormack and ehane (C\\&L) (1 to 4, 4 the worst), without increasing the time taken to intubate (TTI), compared with direct laryngoscopy (DL).\n\nThe investigators secondary hypotheses are that the use of Glidescope and Truview PCD provoke less hemodynamic response and fewer episodes of de-saturation in pediatric patients.', 'detailedDescription': 'Advances in airway management have led to development on videolaryngoscopy devices including the Glidescope® (Verathon Inc, Bothwell, USA), the AWD® (Pentax Corporation, Tokio, Japan) and most recently the Truview PCD (Truphatek International Ltd, Netanya, Israel). The use of videolaryngoscopy devices in adults have demonstrated some advantages including, minimal trauma on the airway and better view of the glottis.\n\nThe Glidescope is designed with a 60º angle and a camera on the inferior aspect just at the inflection point. The view is obtained anteriorly and the camera is located remote from the glottis providing a good visual field. The video image is displayed on a Liquid Crystal Display (LCD), with electronic recording available. Despite a good experience using Glidescope in adults, few studies have been published in pediatric patients. Kim et al. in a randomized study comparing the use of Glidescope with direct laryngoscopy in children, demonstrated better or equal laryngoscopic view with longer time for intubation using the Glidescope.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD'], 'maximumAge': '10 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* ASA physical status I-III\n* elective general surgical procedures\n* from 0-10 years-old\n\nExclusion Criteria:\n\n* increase intracranial pressure\n* history of severe gastrointestinal reflux\n* sore throat\n* upper respiratory airway infection\n* known or suspected difficult airway or coagulopathy'}, 'identificationModule': {'nctId': 'NCT01023568', 'briefTitle': 'Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients', 'organization': {'class': 'OTHER', 'fullName': 'The Cleveland Clinic'}, 'officialTitle': 'Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients', 'orgStudyIdInfo': {'id': '09-902'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Macintosh blade', 'description': 'Intubation with Macintosh blade laryngoscope', 'interventionNames': ['Device: Macintosh blade']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Glidescope', 'description': 'Intubation with Glidescope laryngoscope', 'interventionNames': ['Device: Glidescope']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Truview PCD', 'description': 'Intubation with the Truview PCD laryngoscope', 'interventionNames': ['Device: Truview PCD']}], 'interventions': [{'name': 'Macintosh blade', 'type': 'DEVICE', 'description': 'Intubation with Macintosh blade laryngoscope', 'armGroupLabels': ['Macintosh blade']}, {'name': 'Glidescope', 'type': 'DEVICE', 'description': 'Intubation with Glidescope laryngoscope.', 'armGroupLabels': ['Glidescope']}, {'name': 'Truview PCD', 'type': 'DEVICE', 'description': 'Intubation with Truview PCD laryngoscope.', 'armGroupLabels': ['Truview PCD']}]}, 'contactsLocationsModule': {'locations': [{'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'Cleveland Clinic', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}], 'overallOfficials': [{'name': 'Julie Niezgoda, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'The Cleveland Clinic'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'The Cleveland Clinic', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}